NO942756L - Treatment of glaucoma - Google Patents

Treatment of glaucoma

Info

Publication number
NO942756L
NO942756L NO942756A NO942756A NO942756L NO 942756 L NO942756 L NO 942756L NO 942756 A NO942756 A NO 942756A NO 942756 A NO942756 A NO 942756A NO 942756 L NO942756 L NO 942756L
Authority
NO
Norway
Prior art keywords
treatment
glaucoma
retinal
eye
salts
Prior art date
Application number
NO942756A
Other languages
Norwegian (no)
Other versions
NO942756D0 (en
Inventor
William Cash
Georg Mathis
Marc De Gasparo
Original Assignee
Ciba Vision Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Vision Ag filed Critical Ciba Vision Ag
Publication of NO942756L publication Critical patent/NO942756L/en
Publication of NO942756D0 publication Critical patent/NO942756D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Det blir beskrevet anvendelsen av forbindelser med formel (I), \ (D, hvor er -CH (la) eller X er CH CH3 CH T ----CH---- (lb ), karboksy gruppen er direkte bundet til cyklopentylrlngen l det tilfellet hvor X = (la) og deres salter, ved fremstil- lingen av .farmasøytiske sammensetninger for behandling av glaucoma, for økning av bevegelsen av (retlnalt) intra-okulart fluid, for behandling av vasospastlske tilstander i øyet og for behandling . av diabetisk retlnopatl og også tilsvarende oftalmiske sammen-setninger.It is described the use of compounds of formula (I), \ (D, wherein is -CH (Ia) or X is CH CH3 CH T ---- CH ---- (1b), the carboxy group is directly bonded to the cyclopentyl ring In the case where X = (1a) and their salts, in the preparation of pharmaceutical compositions for the treatment of glaucoma, for increasing the movement of (retinal) intraocular fluid, for the treatment of vasospastic conditions of the eye and for treatment. of diabetic retinopathy and also similar ophthalmic compositions.

NO942756A 1992-02-17 1994-07-22 Treatment of glaucoma NO942756D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH45992 1992-02-17
PCT/US1993/001431 WO1993015732A1 (en) 1992-02-17 1993-02-17 Treatment of glaucoma

Publications (2)

Publication Number Publication Date
NO942756L true NO942756L (en) 1994-07-22
NO942756D0 NO942756D0 (en) 1994-07-22

Family

ID=4187501

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942756A NO942756D0 (en) 1992-02-17 1994-07-22 Treatment of glaucoma

Country Status (8)

Country Link
EP (1) EP0626846A1 (en)
JP (1) JPH07504099A (en)
AU (1) AU3722493A (en)
CA (1) CA2128324A1 (en)
IL (1) IL104755A0 (en)
NO (1) NO942756D0 (en)
WO (1) WO1993015732A1 (en)
ZA (1) ZA931063B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0743852B1 (en) * 1994-02-08 2005-07-27 Novartis AG Treatment of normotensive glaucoma with valsartan
EP0750500A1 (en) * 1994-03-17 1997-01-02 Ciba-Geigy Ag Treatment of diabetic nephropathy with valsartan
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
KR100616466B1 (en) 1998-08-17 2006-08-29 센주 세이야꾸 가부시키가이샤 Preventives/remedies for glaucoma
KR20010074838A (en) * 1998-08-20 2001-08-09 요시다 쇼지 Preventives or remedies for eye circulatory failure
BR0010084A (en) * 1999-04-28 2002-01-15 Takeda Chemical Industries Ltd Pharmaceutical composition, processes to prevent, treat or inhibit the development of simple retinopathy or proliferative retinopathy, and to increase retinal potential or mammalian retinal edema, and, use of a compound
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
FR2878522B1 (en) * 2004-12-01 2008-04-18 Merck Sante Soc Par Actions Si NEW SPECIFIC INHIBITORS OF CASPAS-10

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036048A (en) * 1986-03-07 1991-07-30 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
ATE134624T1 (en) * 1990-02-19 1996-03-15 Ciba Geigy Ag ACYL COMPOUNDS
TW201738B (en) * 1990-03-20 1993-03-11 Sanofi Co
FR2672891B1 (en) * 1991-02-20 1994-02-18 Synthelabo DERIVATIVES OF 3-PYRAZOLONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
CA2128324A1 (en) 1993-08-19
ZA931063B (en) 1993-09-23
WO1993015732A1 (en) 1993-08-19
NO942756D0 (en) 1994-07-22
JPH07504099A (en) 1995-05-11
IL104755A0 (en) 1993-06-10
EP0626846A1 (en) 1994-12-07
AU3722493A (en) 1993-09-03

Similar Documents

Publication Publication Date Title
ES476496A1 (en) Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof, and process for their manufacture.
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
ES8705886A1 (en) Thiazolidinedione derivatives, their production and use.
DE69527799D1 (en) MEDICINES FOR INCREASING CHAMBER WATER OUTFLOW IN GLAUCOMA TREATMENT
AR040806A1 (en) DERIVATIVES OF PIPERIDI-2-ONA 1.6 DISUSTITUTED, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND TREATMENT METHOD
DK0437030T3 (en) Use of 4-substituted imidazoles to reduce intraocular pressure
NO942756L (en) Treatment of glaucoma
CA2081113A1 (en) Thiazolidine-2,4-dione derivative, salt thereof, and production of the same
FI881104A0 (en) Process for the preparation of benzoxazine derivatives for use as antidiabetic agents
NO873722D0 (en) NEW DERIVATIVES OF 4,5-DIHYDRO-OXSAZOLES, AND THE PROCEDURE FOR THEIR PREPARATION.
EP0420606A3 (en) Use of 2-cycloalkylamino oxazolines for reducing or maintaining intraocular pressure
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
KR960003719A (en) Glaucoma Therapeutics and Intraocular Pressure Drops
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
AU6291494A (en) Benzothiazole compound, process for producing the same, and use thereof
NO941932L (en) New [1- (1H-imidazol-4-yl) -alkylA-benzene derivatives, process of their preparation, and eye preparations containing them as active ingredient
NO20020475D0 (en) 2-aminotetraline derivatives for glaucoma therapy
EP0020765A4 (en) Medicament against glaucoma.
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
JPS55102516A (en) Remedy for glaucoma
IE791205L (en) Novel oxothia compounds, processes for their preparation,¹pharmaceutical preparations containing these compounds and¹such compounds for therapeutic use
ES462982A1 (en) 8-azoprostanoic acid derivatives
EP1300150A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension